VYNE Therapeutics Inc.VYNENASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank24
Year-over-Year Change
Year-over-year total asset growth rate
Percentile
P24
Within normal range
vs 2Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -16.53% |
| Q3 2025 | -19.20% |
| Q2 2025 | -20.75% |
| Q1 2025 | -15.67% |
| Q4 2024 | -12.20% |
| Q3 2024 | -12.06% |
| Q2 2024 | -5.48% |
| Q1 2024 | -6.15% |
| Q4 2023 | 407.01% |
| Q3 2023 | -22.81% |
| Q2 2023 | -29.22% |
| Q1 2023 | -13.48% |
| Q4 2022 | -13.11% |
| Q3 2022 | -15.01% |
| Q2 2022 | -14.19% |
| Q1 2022 | -4.07% |
| Q4 2021 | -17.55% |
| Q3 2021 | -39.31% |
| Q2 2021 | -10.18% |
| Q1 2021 | 59.13% |
| Q4 2020 | -12.95% |
| Q3 2020 | -17.70% |
| Q2 2020 | -18.50% |
| Q1 2020 | 102.77% |
| Q4 2019 | -18.02% |
| Q3 2019 | -15.57% |
| Q2 2019 | -9.40% |
| Q1 2019 | -9.77% |
| Q4 2018 | -9.70% |
| Q3 2018 | -7.16% |
| Q2 2018 | -7.52% |
| Q1 2018 | 169.91% |
| Q4 2017 | -11.78% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |